new direction

ok so now its looking like theres going to be 2 companies... fonda and oncology, i brought into acl because ps said fonda would mostly pay for the oncology side so then as far as i see down the track theres going to have to be more raising/placements for oncology for more trails and getting it to market which means more dilution...

on top of that theres going to be another board, which probably means the same board members getting another wage and granting themselves more options.

so as i see it the only winners here are the directors...

this is just my take, am i being to cynical?

a the moment i'm seriously considering selling into any strength.... im lucky i brought at 12c many moons ago lol